Antiemetic Drug Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, Japan - Size and Forecast 2024-2028

Antiemetic Drug Market Size 2024-2028

The antiemetic drug market size is forecast to increase by USD 1.72 million at a CAGR of 6.48% between 2023 and 2028.

• The market is experiencing significant growth due to several key factors. The rising geriatric population globally is a major driver, as this demographic is more susceptible to conditions requiring antiemetic drug treatment. Integration of digital health solutions in antiemetic drug management is another trend, enabling more effective treatment schedules and personalized dosages based on strength and usage. However, patent expiration of major antiemetic drugs poses a challenge, leading to increased competition and potential price erosion. Antihistamines and anticholinergics remain popular drug types in the market, but safety concerns and side effects associated with their use continue to be a challenge for market players. Healthcare expenditure on antiemetic drugs is expected to increase as a result of these trends and challenges.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

• The market encompasses a range of medications used to prevent and alleviate vomiting and nausea associated with various ailments, including gastroenteritis, cancer, and rotavirus gastroenteritis. These conditions can cause significant discomfort and impact the quality of life for patients. The market encompasses a range of medications used to prevent and alleviate vomiting and nausea associated with various ailments, including gastroenteritis, cancer, and rotavirus gastroenteritis. These conditions can cause significant discomfort and impact the quality of life for patients. Antiemetic drugs play a crucial role in managing symptoms of motion sickness, nausea, and vomiting, which can be caused by various factors, such as chemotherapies and motion sickness. Serotonin receptor antagonists, like ondansetron and granisetron, are commonly used antiemetic drugs. Gastrointestinal infections, such as gastroenteritis, are a leading cause of vomiting and nausea. Antiemetic drugs are essential in managing the symptoms of these infections and ensuring patient comfort. Serotonin receptor antagonists, like ondansetron and granisetron, are commonly used antiemetic drugs. Gastrointestinal infections, such as gastroenteritis, are a leading cause of vomiting and nausea. Antiemetic drugs are essential in managing the symptoms of these infections and ensuring patient comfort.

• Cancer patients undergoing chemotherapy often experience severe nausea and vomiting as side effects. Antiemetic drugs help alleviate these symptoms, allowing patients to better tolerate their treatment and improve their overall well-being. Cancer diagnostic patients undergoing chemotherapy often experience severe nausea and vomiting as side effects. Retail pharmacies, such as CVS Pharmacy, Walgreens Boots Alliance, and Rite Aid, play a significant role in providing access to antiemetic drugs for patients. These pharmacies offer both branded and generic substitutes, providing patients with affordable options to manage their symptoms. Cumberland Pharmaceuticals, Sancuso, and Sandoz are key players in the market, offering various antiemetic drugs to cater to the diverse needs of patients. Antiemetic drugs are also used to manage symptoms of vertigo and motion sickness.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Drug Class
  • 5-Hydroxytryptamine 3
  • Dopamine antagonist
  • Neurokinin-1 (NK 1) receptor antagonist
  • Cannabinoid receptor antagonist
  • Others
• Application
  • Chemotherapy
  • Surgery
  • Gastroenteritis
  • Others
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

By Drug Class Insights

• The 5-hydroxytryptamine 3 segment is estimated to grow significantly during the forecast period.

5-HT3 receptor antagonists are a widely utilized drug class for mitigating vomiting and nausea. These medications inhibit the effect of serotonin on 5-HT3 receptors, which are situated in the gastrointestinal tract and the central nervous system. By obstructing the activation of these receptors, 5-HT3 receptor antagonists effectively minimize the feeling of nausea and the frequency of vomiting. A significant application of these drugs lies in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). Chemotherapy treatments trigger the discharge of serotonin, stimulating 5-HT3 receptors and resulting in nausea and vomiting.

Furthermore, generic substitutes of these medications are also available, offering cost-effective alternatives for patients. Gastrointestinal disorders like gastroenteritis and rotavirus gastroenteritis can also benefit from the use of 5-HT3 receptor antagonists. These drugs play a crucial role in enhancing patients' quality of life by alleviating symptoms of nausea and vomiting.

Get a glance at the market report of share of various segments Request Free Sample

The 5-Hydroxytryptamine 3 segment was valued at USD 1.36 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 41% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market in North America accounted for the largest share in the global market in 2023. This region, consisting of the United States, Canada, and Mexico, is a significant contributor to the development, production, and utilization of antiemetic drugs. The market's growth in North America is attributed to several factors. Firstly, the region has a substantial prevalence of medical conditions, such as cancer, gastrointestinal disorders, and vertigo, necessitating antiemetic drug therapy. The market in North America is further driven by the availability of advanced antiemetic drugs, such as dopamine receptor antagonists and neurokinin receptor antagonists, and the increasing use of general anaesthetics in medical procedures. Moreover, motion sickness, a common condition, is prevalent among the population, particularly among travelers.

Antiemetic drugs are essential in managing emesis (vomiting) and other symptoms associated with various ailments, including chemotherapies' side effects. The market in North America is further driven by the availability of advanced antiemetic drugs, such as dopamine receptor antagonists and neurokinin receptor antagonists, and the increasing use of general anesthetics in medical procedures. The market's growth is also fueled by the increasing focus on research and development activities and the growing awareness of the importance of managing emesis and related symptoms effectively.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Antiemetic Drug Market?

The rising geriatric population globally is the key driver of the market.

• The market is experiencing growth due to the increasing prevalence of medical conditions that lead to nausea and vomiting, particularly among the elderly population. With advancements in healthcare and longer life expectancy, the proportion of older adults in the global population has been rising. Elderly individuals are more susceptible to medical conditions such as cancer, which often requires chemotherapy, and metabolic disorders that can result in dizziness, dehydration, and nutritional depletion. Food poisoning and emotional stress are other common causes of nausea and vomiting.

• Antiemetic drugs play a crucial role in managing these symptoms and ensuring patient comfort and well-being. The market for these drugs is expected to continue growing as the geriatric population expands and the need for effective antiemetic treatments increases.

What are the market trends shaping the Antiemetic Drug Market?

Integration of digital health solutions in antiemetic drug management is the upcoming trend in the market.

• The market is experiencing significant growth due to the increasing use of these medications in post-operative surgery and cancer cases. Hospital pharmacies and online pharmacies are major contributors to this market's expansion. Telehealth platforms are revolutionizing antiemetic drug management, particularly in the context of surgical procedures and radiation therapy. These digital health solutions enable remote monitoring and management of symptoms related to nausea and vomiting. Telehealth platforms facilitate real-time communication between patients and healthcare providers through video consultations and virtual visits. This innovation enhances patient convenience, enables timely interventions, and reduces the need for hospital visits. The integration of antiemetics into digital health solutions is a promising trend in the healthcare industry.

What challenges does Antiemetic Drug Market face during its growth?

Side effects and safety concerns associated with antiemetic drugs is a key challenge affecting the market growth.

• Antiemetic drugs are essential in managing nausea and vomiting, but their usage is not without challenges. One of the significant issues is the side effects associated with these medications. Common side effects include drowsiness, dizziness, constipation, and dry mouth. These side effects can negatively impact a patient's daily activities, quality of life, and treatment adherence. For instance, the sedating effects of specific antiemetic drugs may hinder a patient's ability to drive or operate machinery, leading to functional impairment and decreased well-being. Moreover, patent expiration and treatment schedules influence the market. As patents expire, generic alternatives become available, leading to increased competition and potentially lower prices.

• However, this can also impact dosage strength and usage, as generic versions may not always be identical to their branded counterparts. Healthcare expenditure is another critical factor in the market. Antiemetic drugs come in various types, such as antihistamines and anticholinergics. The cost of these medications can vary significantly, impacting healthcare budgets and patient access. It is essential to consider these factors when analyzing the market trends.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast , partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Algen Healthcare Ltd.
• Boehringer Ingelheim International GmbH
• Bristol Laboratories Ltd.
• Cadila Pharmaceuticals Ltd.
• Cipla Inc.
• Eagle Pharmaceuticals Inc.
• Fresenius SE and Co. KGaA
• GlaxoSmithKline Plc
• Helsinn Healthcare SA
• Heron Therapeutics Inc.
• Lupin Ltd.
• Merck and Co. Inc.
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• RedHill Biopharma Ltd.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Antiemetic drugs are essential medications used to prevent and manage vomiting and nausea caused by various ailments such as gastroenteritis, chemotherapy, postoperative surgery, vertigo, motion sickness, and emotional stress. These conditions can lead to dehydration and nutritional depletion, making timely intervention crucial. Gastrointestinal infections like rotavirus gastroenteritis and cancer are common causes of vomiting and nausea. Antiemetic drugs like ondansetron (Zofran) and barhemsys are popular choices due to their effectiveness against chemotherapies and postoperative surgery. Serotonin receptor antagonists, dopamine receptor antagonists, and neurokinin receptor antagonists are the primary drug types used in antiemetic therapy.

Furthermore, the market is significant due to the increasing number of cancer cases and surgeries, as well as the availability of generic substitutes. Antiemetic drugs are also used in hospital pharmacies and online pharmacies for surgical procedures, radiation therapy, and raw material estimations. The market's growth is influenced by factors like treatment schedules, patent expiration, dosage, strength, usage, healthcare expenditure, and drug type. Antihistamines and anticholinergics are alternative options for antiemetic therapy. The market's future looks promising due to the rising number of cancer cases and surgeries, as well as the development of new antiemetic drugs.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch